Skip to content

688315.SH

诺禾致源

SSE · Healthcare · Biotechnology · CN

CNY 16.93
+6.14%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue2.3B2.2B2.1B2.0B1.9B
Cost of Revenue1.3B1.3B1.2B1.1B1.1B
Gross Profit974.4M939.8M923.6M855.6M852.7M
Operating Expenses
R&D Expense166.5M159.9M131.4M124.2M125.6M
SG&A Expense
General & Admin Expense145.3M145.3M158.3M177.6M172.2M
Selling & Marketing Expense461.5M443.6M406.0M379.1M331.6M
Other Expenses
Total Operating Expenses776.2M741.2M694.7M670.6M626.2M
Cost and Expenses2.1B2.0B1.9B1.8B1.7B
Operating Income (EBIT)192.8M193.5M234.0M214.9M212.5M
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)192.3M192.9M224.7M212.6M208.6M
Income Tax Expense24.9M21.4M20.9M29.4M27.0M
Bottom Line
Net Income162.5M166.9M196.8M178.1M177.2M
Earnings from Cont. Ops167.5M171.5M203.8M183.2M181.5M
Earnings from Discont. Ops
Bottom Line Net Income162.5M166.9M196.8M178.1M177.2M
Per Share
Basic EPSCN¥0.40CN¥0.41CN¥0.48CN¥0.44CN¥0.44
Diluted EPSCN¥0.40CN¥0.41CN¥0.48CN¥0.44CN¥0.44
Revenue Per ShareCN¥5.38CN¥5.43CN¥5.15CN¥4.95CN¥4.78
Shares
Basic Shares Outstanding420.7M407.2M410.0M404.7M402.8M
Diluted Shares Outstanding420.7M407.2M410.0M404.7M402.8M
Profitability Metrics
EBITDA325.8M376.1M347.6M330.2M
D&A132.3M142.1M132.7M117.8M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026